title: [The mechanism of action of valsartan studied by HPLC-TOF/MS].
abstract: High performance liquid chromatography-time-off-flight mass spectrometer (HPLC-TOFMS) technology coupled with partial least squares discriminant analysis (PLS-DA) processed by SIMCA-P software was applied to investigate serum endogenous metabolites alternations of valsartan in spontaneous hypertension rats (SHR). And MetPA platform was used to connect identified potential biomarkers in corresponding metabolic pathways to find possible therapeutic mechanism of valsartan. Valsartan significantly declined the blood pressure of SHRs (P < 0.05) at fourth week. The metabolic profiling significantly changed and four metabolites involved in G protein-coupled pathway were identified. Metabolomics is able to detect holistic and microcosmic alternations in organism, so as to elucidate therapeutic mechanism of drugs.
authors.forename: Wen-qing
authors.initials: WQ
authors.lastname: Yang
authors.forename: Yun-lun
authors.initials: YL
authors.lastname: Li
authors.forename: Hai-qiang
authors.initials: HQ
authors.lastname: Jiang
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure; D002851:Chromatography, High Pressure Liquid; D016002:Discriminant Analysis; D016018:Least-Squares Analysis; D013058:Mass Spectrometry; D055442:Metabolome; D055432:Metabolomics; D051381:Rats; D011918:Rats, Inbred SHR; D000068756:Valsartan / Q000494:pharmacology*
chemical_list: D015415:Biomarkers; D000068756:Valsartan